Lizzy Lawrence , 2025-05-08 02:15:00
WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his admiration for agency employees, and his desire to serve the American public.
The new director of the Center for Biologics Evaluation and Research sounded very different from his online firebrand persona. He struck a humble, self-deprecating, and even earnest tone, calling the American people the agency’s “number one stakeholder.”
“My academic research discipline is epidemiology, evidence-based medicine,” Prasad said in a recording obtained by STAT. “I applaud what you do. I’ve learned a lot from reading your papers over the last 20 years.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
